Closed System Transfer Devices Market Outlook:
Closed System Transfer Devices Market size was valued at USD 1.44 billion in 2025 and is expected to reach USD 3.8 billion by 2035, expanding at around 10.2% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of closed system transfer devices is evaluated at USD 1.57 billion.
The growth of this market can be attributed to the growing number of cancer cases globally. It has led to a positive rise in the implementation of chemotherapy treatment all over the world. According to WHO, more than 10 million people worldwide died from cancer in 2020. Additionally, according to projections from the IARC and WHO, there would be 19.3 million new instances of cancer worldwide by 2025. In addition, a sharp rise in the number of oncology drug approvals is another important aspect that significantly boosts this market's expansion effectively.
Moreover, the growing demand for monitoring compliance for safe pharmaceutical handling is expected to drive the growth of the closed system transfer device market. It is possible to determine differences in safety compliance between several groups using ANOVA (Analysis of Variance). Antineoplastic drugs can save or improve a patient's survival but on the other side can be detrimental to the health of medical workers. This might occur in cases when medicine escapes during administration, compounding, or patient delivery or in case there is service contamination. Therefore, pharmacy professionals at cancer centers prepare all types of chemotherapy drugs under the supervision of a professional pharmacist.
